AMSTERDAM, Nov 3 (Reuters) - Dutch speciality chemicals
company DSM on Tuesday beat analysts' expectations for
third-quarter core profit, as industrial demand for its
plastics, fibres and other materials recovered from a
DSM said, however, sales fell 4% year-on-year to 1.96
billion euros ($2.28 billion) for the quarter ended Sept. 30,
led by a 17% decrease in its materials division.
Revenue at the larger nutrition division remained stable, as
the pandemic fuelled demand for DSM's vitamins and other food
"Conditions were overall good in Nutrition, with momentum in
Materials improving," co-Chief Executive Officers Geraldine
Matchett and Dimitri de Vreeze said in a statement.
"Materials, whilst still impacted by COVID-19, showed an
improving volume trend relative to the prior quarter, especially
The recent surge in COVID-19 patients, however, make it
impossible to say whether this improvement will last, DSM said,
as it declined to give an outlook for its full-year results.
The company posted a 1% drop on-year in adjusted earnings
before interest, taxes, depreciation and amortisation (EBITDA)
to 383 million euros for the quarter.
Analysts polled by the company on average had predicted
adjusted EBITDA of 369 million euros on 2.01 billion euros of
($1 = 0.8580 euros)
(Reporting by Bart Meijer; Editing by Kim Coghill and Rashmi